These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8669885)

  • 21. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
    Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
    J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
    Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
    Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
    Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K
    Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
    Meneses AM; Medina RA; Kato S; Pinto M; Jaque MP; Lizama I; García Mde L; Nualart F; Owen GI
    J Cell Physiol; 2008 Jan; 214(1):110-6. PubMed ID: 17559076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
    Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer.
    Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M
    Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
    Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
    Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of glycoprotein pMQ1 in breast cancer.
    Fon LJ; Lioe TF; Mulligan KA; Johnston PG; McCormick D; Spence RA
    Br J Surg; 2006 Mar; 93(3):309-14. PubMed ID: 16392102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
    Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
    Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.